Authors
Courtney R Rivet-Noor, Andrea R Merchak, Caroline Render, Naudia M Gay, Rebecca M Beiter, Ryan M Brown, Austin Keeler, G Brett Moreau, Sihan Li, Deniz G Olgun, Alexandra D Steigmeyer, Rachel Ofer, Tobey Phan, Kiranmayi Vemuri, Lei Chen, Keira E Mahoney, Jung-Bum Shin, Stacy A Malaker, Chris Deppmann, Michael P Verzi, Alban Gaultier
Publication date
2024/7/1
Journal
Brain, Behavior, and Immunity
Volume
119
Pages
665-680
Publisher
Academic Press
Description
Depression is a prevalent psychological condition with limited treatment options. While its etiology is multifactorial, both chronic stress and changes in microbiome composition are associated with disease pathology. Stress is known to induce microbiome dysbiosis, defined here as a change in microbial composition associated with a pathological condition. This state of dysbiosis is known to feedback on depressive symptoms. While studies have demonstrated that targeted restoration of the microbiome can alleviate depressive-like symptoms in mice, translating these findings to human patients has proven challenging due to the complexity of the human microbiome. As such, there is an urgent need to identify factors upstream of microbial dysbiosis. Here we investigate the role of mucin 13 as an upstream mediator of microbiome composition changes in the context of stress. Using a model of chronic stress, we show …
Scholar articles
CR Rivet-Noor, AR Merchak, C Render, NM Gay… - Brain, Behavior, and Immunity, 2024